10-KPeriod: FY2021

METLIFE INC Annual Report, Year Ended Dec 31, 2021

Filed February 18, 2022For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife Inc.'s 2021 Form 10-K, filed on February 17, 2022, highlights a business operating within a complex and uncertain economic landscape. The report extensively details a wide array of risks and uncertainties that could materially impact the company's future financial performance. These include macroeconomic factors such as interest rate fluctuations, credit market volatility, and public health concerns (like COVID-19), alongside operational risks including cybersecurity threats, regulatory changes, and integration challenges from potential acquisitions or reorganizations. Investors should pay close attention to MetLife's risk factors section, which outlines numerous potential headwinds. The company explicitly states that its forward-looking statements are subject to these unpredictable risks and do not guarantee future performance. Key concerns revolve around the company's ability to manage its financial strength, credit ratings, and investment portfolio amidst market volatility, as well as its capacity to adapt to evolving regulatory environments and technological advancements. The separation from Brighthouse Financial, Inc. and its related risks are also noted.

Financial Highlights

43 data points
Beta

Revenue

$68.70B

Net Income

$6.88B

10.0% Net Margin

EPS (Diluted)

$7.65

Total Assets

$759.71B

Cash & Equivalents

$20.05B

Free Cash Flow

$12.35B

Financial Statements
Beta
Revenue$68.70B
Operating Expenses$12.02B
Interest Expense$647.00M
Net Income$6.88B
EPS (Basic)$7.71
EPS (Diluted)$7.65
Shares Outstanding (Basic)862.70M
Shares Outstanding (Diluted)869.40M

Key Highlights

  • 1Extensive disclosure of numerous risks and uncertainties that could impact future financial results, including economic, market, regulatory, and operational factors.
  • 2Emphasis on the unpredictable nature of forward-looking statements and the potential for material differences between projections and actual results.
  • 3Mention of global capital and credit market adversity as a key risk factor.
  • 4Identification of potential downgrades in financial strength or credit ratings as a concern.
  • 5Acknowledgement of risks associated with reinsurance, statutory reserve financing, and market capacity.
  • 6Highlighting of evolving regulatory and tax landscapes as potential challenges.
  • 7Specific mention of risks related to the discontinuation of LIBOR and the transition to alternative reference rates.

Frequently Asked Questions

MetLife Inc. faces a broad spectrum of risks categorized into economic conditions (including public health, interest rates, credit, equity, and currency risks), global capital and credit market adversities, financial strength and credit rating risks, reinsurance and financing costs, legal and regulatory changes, tax law changes, litigation and investigations, market interest rate transitions (like LIBOR), environmental, social, and governance (ESG) standards, dividend and capital return capabilities, investment performance and valuation, operational risks (including cybersecurity and disaster recovery), and business strategy risks (such as competition, technological changes, and acquisition difficulties).

MetLife Inc. explicitly states that its forward-looking statements depend on assumptions, expectations, and understanding of the economic environment, which may be inaccurate and subject to change. The company does not guarantee future performance and warns that actual results could differ materially from those expressed or implied. They encourage investors to consult subsequent SEC filings for further disclosures on related subjects and will not publicly correct or update these statements if they believe they are unlikely to be achieved.

Yes, the filing specifically mentions 'Brighthouse Financial, Inc. separation risks,' indicating that the divestiture of Brighthouse Financial continues to present potential challenges and uncertainties for MetLife Inc. Investors should be aware of any ongoing implications from this separation.

The filing notes a risk related to the 'MetLife, Inc.’s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust.' This suggests a governance-related risk where the trust's voting provisions could potentially influence corporate decisions and outcomes, which is an important consideration for shareholder rights and corporate control.